On June 6, Futu News reported that $RIMAG GROUP (02522.HK)$Today's dark market opened at a low of 4.14%, and as of the writing, it was reported at 14.36 Hong Kong dollars, with a turnover of 6.9637 million Hong Kong dollars and a total market value of 5.117 billion Hong Kong dollars.
Market source: Futu Securities.
Company overview
Yiyi Yangguang is a leading medical imaging specialist medical group in China. According to Frost & Sullivan's data, in 2023, the company ranked first among all third-party medical imaging center operators in China based on the number of medical imaging center network nodes, number of equipment, number of registered imaging doctors registered with the company as their main workplace, daily examination volume, and patient payment fees. Based on the revenue generated by image center services in 2023, the company ranked second among all third-party medical imaging center operators in China. According to the same data source, Yiyi Yangguang is also the only medical imaging platform operator and manager in China that provides diversified image services and values for the entire medical imaging industry chain.
The company mainly generates revenue through the following medical imaging services and solutions: (i) Image center services. The company operates its own medical imaging center and provides a variety of image inspection and diagnosis services, or provides operational management services to partner medical imaging centers; (ii) Image solution services. In 2019, the company began to provide image solution services to customers. Its image solution mainly helps hospital and other medical institutions customers to select and purchase suitable image equipment that meet their development needs. In order to maximize the value of image equipment use, the company provides them with a series of supporting modular solutions; (iii) Yiyi cloud service. In order to support the development of image center service business, the company has also developed the Yiyi cloud platform to provide internal business development, information management and data-driven operation. In 2018, as its products and services continued to develop, the company commercialized Yiyi cloud service and provided related services to China's medical imaging industry under the Yiyi Yangguang brand.
Financial overview
In terms of financial status, Yiyi Yangguang's revenue in 2021, 2022, and 2023 was RMB 592 million, RMB 784 million, and RMB 929 million, respectively, with a compound annual growth rate of 25.26% from 2021 to 2023; the gross profit for the same period was RMB 175 million, RMB 237 million, and RMB 333 million, respectively, with a compound annual growth rate of 37.79% from 2021 to 2023. The company's annual losses for the same period were RMB -382 million and -15.058 million, respectively. In 2023, it turned losses into profits and realized a net profit of RMB 36.574 million for the year.
Editor/Wilde